Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples